These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8785241

  • 1. Absorption and clearance of ceftazidime during CAPD.
    Plant WD, Martin U, Barron W, Scouse PK, Winney RJ, Prescott LF.
    Perit Dial Int; 1995; 15(8):378-82. PubMed ID: 8785241
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
    Grabe DW, Bailie GR, Eisele G, Frye RF.
    Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Manley HJ, Bailie GR, Asher RD, Eisele G, Frye RF.
    Perit Dial Int; 1999 Jan; 19(1):65-70. PubMed ID: 10201343
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
    Peerapornratana S, Chariyavilaskul P, Kanjanabuch T, Praditpornsilpa K, Eiam-Ong S, Katavetin P.
    Perit Dial Int; 2017 Jan; 37(2):218-224. PubMed ID: 27738089
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of peritonitis under continuous ambulatory peritoneal dialysis using intraperitoneal ceftazidime].
    Ragnaud JM, Dupon M, Morlat P, Bezian MC, Wone C.
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):681-4. PubMed ID: 2677930
    [Abstract] [Full Text] [Related]

  • 13. Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Matzke GR, Frye RF, Joy MS, Palevsky PM.
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1639-44. PubMed ID: 10817721
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.
    Elwell RJ, Bailie GR, Manley HJ.
    Perit Dial Int; 2000 Jun; 20(6):694-8. PubMed ID: 11216561
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of ceftazidime in loggerhead sea turtles (Caretta caretta) after single intravenous and intramuscular injections.
    Stamper MA, Papich MG, Lewbart GA, May SB, Plummer DD, Stoskopf MK.
    J Zoo Wildl Med; 1999 Mar; 30(1):32-5. PubMed ID: 10367641
    [Abstract] [Full Text] [Related]

  • 19. On-line solid-phase extraction of ceftazidime in serum and determination by high-performance liquid chromatography.
    Bompadre S, Ferrante L, Alò FP, Leone L.
    J Chromatogr B Biomed Appl; 1995 Jul 21; 669(2):265-9. PubMed ID: 7581902
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.